NO20065057L - benzoksazociner og terapeutisk anvendelse derav som monoamin reopptaks inhibitorer - Google Patents

benzoksazociner og terapeutisk anvendelse derav som monoamin reopptaks inhibitorer

Info

Publication number
NO20065057L
NO20065057L NO20065057A NO20065057A NO20065057L NO 20065057 L NO20065057 L NO 20065057L NO 20065057 A NO20065057 A NO 20065057A NO 20065057 A NO20065057 A NO 20065057A NO 20065057 L NO20065057 L NO 20065057L
Authority
NO
Norway
Prior art keywords
optionally substituted
alkyl
unsubstituted
cycloalkyl
alkenyl
Prior art date
Application number
NO20065057A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew Douglas Baxter
Andrea Walmsley
Elena Lasterra
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0408862A external-priority patent/GB0408862D0/en
Priority claimed from GB0408863A external-priority patent/GB0408863D0/en
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20065057L publication Critical patent/NO20065057L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20065057A 2004-04-21 2006-11-02 benzoksazociner og terapeutisk anvendelse derav som monoamin reopptaks inhibitorer NO20065057L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0408862A GB0408862D0 (en) 2004-04-21 2004-04-21 Novel benzoxazocines
GB0408863A GB0408863D0 (en) 2004-04-21 2004-04-21 Novel benzoxazocines
PCT/GB2005/001519 WO2005103019A1 (en) 2004-04-21 2005-04-21 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors

Publications (1)

Publication Number Publication Date
NO20065057L true NO20065057L (no) 2006-11-21

Family

ID=34965745

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065057A NO20065057L (no) 2004-04-21 2006-11-02 benzoksazociner og terapeutisk anvendelse derav som monoamin reopptaks inhibitorer

Country Status (8)

Country Link
EP (1) EP1740558A1 (pt)
JP (1) JP2007533718A (pt)
AU (1) AU2005235786A1 (pt)
BR (1) BRPI0510075A (pt)
CA (1) CA2558741A1 (pt)
IL (1) IL177750A0 (pt)
NO (1) NO20065057L (pt)
WO (1) WO2005103019A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504960D0 (en) * 2005-03-10 2005-04-20 Arakis Ltd Benzoxazocines
GB0506835D0 (en) * 2005-04-04 2005-05-11 Arakis Ltd Therapeutic use of nefopam
US8957107B2 (en) 2009-12-15 2015-02-17 The Hospital For Sick Children Method of treating scars and β-catenin-mediated disorders using Nefopam compounds
BR112013000925A2 (pt) 2010-07-15 2020-12-01 Bayer Intellectual Property Gmbh compostos heterocíclicos como pesticidas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) * 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones
US3978085A (en) * 1975-03-07 1976-08-31 Riker Laboratories, Inc. Process for benz[f]-2,5-oxazocines
JPS5913760A (ja) * 1982-07-13 1984-01-24 Sanwa Kagaku Kenkyusho:Kk 新規の2−ベンズアゾシン誘導体及びその製法
JPS5913770A (ja) * 1982-07-13 1984-01-24 Sanwa Kagaku Kenkyusho:Kk 新規の1−フエニル−2,5−ベンゾチアゾシン誘導体及びその製法
WO2001032625A1 (en) * 1999-11-03 2001-05-10 Du Pont Pharmaceuticals Company Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ATE404543T1 (de) * 2002-12-20 2008-08-15 Sosei R & D Ltd Benzoxazocine und ihre verwendung als monoamin- wiederaufnahme inhibitoren

Also Published As

Publication number Publication date
AU2005235786A1 (en) 2005-11-03
WO2005103019A1 (en) 2005-11-03
IL177750A0 (en) 2006-12-31
JP2007533718A (ja) 2007-11-22
BRPI0510075A (pt) 2007-10-16
EP1740558A1 (en) 2007-01-10
CA2558741A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CO2017001603A2 (es) Compuestos aminopirimidinilo inhibidores de jak
NO20072116L (no) Farmasoytiske forbindelser
MX2015015893A (es) 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen.
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
AR046938A1 (es) Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
DE602004014347D1 (de) Chinazolin-derivate als tgf-beta-inhibitoren
HRP20041042A2 (hr) Novi supstituirani derivati sulfamata kao antikonvulzivi
AR041297A1 (es) Derivados de 4-pirrolidino- fenil- bencil eter
NZ601967A (en) Pde10 inhibitors and related compositions and methods
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
CY1114702T1 (el) Νεοι εναnτιομερως καθαροι βητα αγωνιστες, μεθοδος για την παραγωγη τους και χρηση αυτων ως φαρμακων
JOP20190239A1 (ar) مركبات مثبطة لـ vmat2 وتركيبات منها
AR040489A1 (es) Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen
TW200510377A (en) Novel compound having 4-pyridylalkylthio group as substituent
ATE535241T1 (de) Verwendung von 3-(indolyl)- oder 3-(azaindolyl)-4-arylmaleimid-derivaten bei der behandlung von leukämie
NO20071319L (no) Fremgangsmate for fremstilling av isotiazolderivater.
NO20054095L (no) Pyridyloksymetyl og benzioksazolazabicyklisk derivater
NO20063330L (no) Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
TW200517387A (en) Compounds exhibiting thrombopoietin receptor agonism
RU2011116164A (ru) Новые производные оксазолидинона с циклическим амидоксимом или циклическим амидразоном и содержащие их фармацевтические композиции
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
EA201071014A1 (ru) Новые 7-замещенные производные 3-карбоксиоксадиазинохинолонов, способ их получения и применение в качестве антибактериальных средств

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application